Molecular targets for flavivirus drug discovery
- 15 September 2008
- journal article
- review article
- Published by Elsevier BV in Antiviral Research
- Vol. 81 (1), 6-15
- https://doi.org/10.1016/j.antiviral.2008.08.004
Abstract
No abstract availableKeywords
This publication has 178 references indexed in Scilit:
- Closing the door on flaviviruses: Entry as a target for antiviral drug designAntiviral Research, 2008
- Flavivirus methyltransferase: A novel antiviral targetAntiviral Research, 2008
- Review: Hepatitis C Protease and Polymerase Inhibitors in DevelopmentAIDS Patient Care and STDs, 2008
- Specific requirements for elements of the 5′ and 3′ terminal regions in flavivirus RNA synthesis and viral replicationVirology, 2008
- Interaction of TIA-1/TIAR with West Nile and dengue virus products in infected cells interferes with stress granule formation and processing body assemblyProceedings of the National Academy of Sciences, 2007
- Expression and purification of a two-component flaviviral proteinase resistant to autocleavage at the NS2B–NS3 junction regionProtein Expression and Purification, 2007
- Cleavage preference distinguishes the two-component NS2B–NS3 serine proteinases of Dengue and West Nile virusesBiochemical Journal, 2007
- A structural perspective of the flavivirus life cycleNature Reviews Microbiology, 2005
- Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue virusesNature Medicine, 2004
- DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic CellsThe Journal of Experimental Medicine, 2003